CIK 0000879407
- Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460408024
- Phone
- +1 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Open-market sale Chief Executive Officer sold 164,834 shares at $14.45 ($2,381,851)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at $14.01 ($280,200)
- 4 Open-market sale Chief Financial Officer sold 14,000 shares at $11.00 ($154,000)
- 4 Open-market sale Director sold 25,000 shares at $6.63 ($165,750)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at $8.00 ($160,000)
- 4 Open-market sale Chief Executive Officer sold 26,000 shares at $7.40 ($192,400)
- 4 Open-market sale Chief Executive Officer sold 300,000 shares at an average $7.43 ($2,228,000)
- 4 Open-market sale Chief Operating Officer sold 20,000 shares at $6.73 ($134,600)
- 4 Shares withheld for taxes Chief Financial Officer gave up 8,208 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award VP, Strategic Bus. Initiatives acquired 40,000 shares (grant or award)
- 4 Grant or award General Counsel acquired 60,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 20,000 shares at $3.69 ($73,800)
- 4 Grant or award Chief Executive Officer acquired 500,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 14 of 25 · 497 filings